SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)
Clinical trial NCT02437487 · COMPLETED
Trial details
- NCT number
- NCT02437487
- Sponsor
- Seres Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-07-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.